Dr. Barry Reiner, MD (he/him) is a Pediatric Endocrinologist in Baltimore, MD with over 18 years of experience. What is your opinion of Dr. Barry Reiner, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Barry Reiner, MD has received over $97,038 which includes payments from the following companies:
$26,002.59 from Novo Nordisk AS
$22,448.56 from Pfizer Inc.
$17,230.98 from ELI LILLY AND COMPANY
$12,503.77 from Novo Nordisk Inc
$6,766.17 from Tandem Diabetes Care, Inc.
$3,858.14 from Animas Corporation
$2,233.86 from Merck Sharp & Dohme Corporation
$1,206.03 from Daiichi Sankyo Inc.
$1,109.58 from Genentech, Inc.
$487.40 from AbbVie, Inc.
$428.09 from LILLY USA, LLC
$422.10 from sanofi-aventis U.S. LLC
$396.61 from MannKind Corporation
$369.01 from Medtronic MiniMed, Inc.
$337.26 from INSULET CORPORATION
$170.10 from Ferring Pharmaceuticals Inc.
$134.25 from Arbor Pharmaceuticals, Inc.
$87.83 from Sandoz Inc.
$73.31 from Becton, Dickinson and Company
$72.11 from Companion Medical, Inc.
Payments received by Dr. Barry Reiner, MD were from the following categories:
$52,855.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!